Virpax Pharmaceuticals In...
(VRPX)
undefined
undefined%
At close: undefined
0.37
-10.51%
Pre-market Dec 16, 2024, 05:50 AM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Income | -15.69M | -21.85M | -12.03M | -4.20M | -3.18M | -2.63M |
Interest Income | - | - | 92.82 | 147.93 | 124.64 | - |
Pretax Income | -15.19M | -21.65M | -12.06M | -4.34M | -3.31M | -2.64M |
Net Income | -15.19M | -21.46M | -12.15M | -4.49M | -3.43M | -2.64M |
Selling & General & Admin | 11.82M | 11.08M | 7.19M | 2.90M | 2.56M | 1.48M |
Research & Development | 5.12M | 10.76M | 4.84M | 1.29M | 622.74K | 1.14M |
Other Expenses | - | 194.41K | 62.26K | 4.00K | - | - |
Operating Expenses | 15.69M | 21.85M | 12.03M | 4.20M | 3.18M | 2.63M |
Interest Expense | - | - | 92.82K | 147.93K | 124.64K | 14.98K |
Selling & Marketing Expenses | 4.00M | - | - | - | - | - |
Cost & Expenses | 15.69M | 21.85M | 12.03M | 4.20M | 3.18M | 2.63M |
Income Tax | - | -194.41K | 92.82K | 147.93K | 124.64K | -161.14K |
Shares Outstanding (Basic) | 1.17M | 1.17M | 1.17M | 494.51K | 521.51K | 4.95M |
Shares Outstanding (Diluted) | 1.17M | 1.17M | 1.17M | 494.51K | 521.51K | 4.95M |
EPS (Basic) | -12.97 | -18.32 | -10.37 | -9.07 | -6.58 | -0.53 |
EPS (Diluted) | -12.97 | -18.32 | -10.37 | -9.07 | -6.58 | -0.53 |
EBITDA | -15.19M | - | - | -4.19M | - | - |
Depreciation & Amortization | 500.28K | 18.35M | 12.03M | 4.20M | 3.18M | 2.63M |